title: Risk of major bleeding and the standard doses of dabigatran.
authors.affiliation: Univ Bordeaux, Inserm U657, F33000 Bordeaux, France; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, I20157 Milan, Italy. Electronic address: stefania.antoniazzi@unimi.it.
authors.forename: Stefania
authors.initials: S
authors.lastname: Antoniazzi
authors.affiliation: CHU Bordeaux, F33000 Bordeaux, France.
authors.forename: Driss
authors.initials: D
authors.lastname: Berdaï
authors.affiliation: Regional Centre for Pharmacovigilance, Lombardy Region, via Rosellini 17, I20124 Milan, Italy.
authors.forename: Valentino
authors.initials: V
authors.lastname: Conti
authors.affiliation: Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", Università di Milano, I20157 Milan, Italy; E. Medea Scientific Institute, I23842 Bosisio Parini, Italy.
authors.forename: Emilio
authors.initials: E
authors.lastname: Clementi
authors.affiliation: Univ Bordeaux, Inserm U657, F33000 Bordeaux, France; CHU Bordeaux, F33000 Bordeaux, France.
authors.forename: Francesco
authors.initials: F
authors.lastname: Salvo
mesh_terms: D000991:Antithrombins / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D054556:Venous Thromboembolism / Q000517:prevention & control*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran
keywords: Anticoagulants; Atrial fibrillation; Meta-analysis; Review; Venous thromboembolism